| Lois Evelyn Taulbee, LPN | |
|
3030 Chestnut St, Lebanon, PA 17042-2518 | |
| (717) 273-8000 | |
| (717) 273-8244 |
| Full Name | Lois Evelyn Taulbee |
|---|---|
| Gender | Female |
| Speciality | Licensed Practical Nurse |
| Location | 3030 Chestnut St, Lebanon, Pennsylvania |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1427669902 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 164W00000X | Licensed Practical Nurse | PN075550L (Pennsylvania) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Lois Evelyn Taulbee, LPN 3030 Chestnut St, Lebanon, PA 17042-2518 Ph: (717) 273-8000 | Lois Evelyn Taulbee, LPN 3030 Chestnut St, Lebanon, PA 17042-2518 Ph: (717) 273-8000 |
News Archive
Teva Pharmaceutical Industries Ltd. announced today that the U.S. Food and Drug Administration (FDA) has granted tentative approval for the Company's Abbreviated New Drug Application (ANDA) to market its generic version of Novartis' breast cancer treatment Femara® (letrozole) Tablets, 2.5 mg. Final approval of Teva's Letrozole Tablets is expected upon expiry of patent protection for the brand product in June 2011.
Dongsheng Pharmaceutical International Co., Ltd. announced today that it has entered into an agreement with Shanghai Wan'Te Pharmaceutical Co., Ltd. to acquire the intellectual property, exclusive sales and manufacturing rights of micro-emulsion alprostadil injection from Wan'Te for total proceeds of RMB10 million, of which RMB5 million will be paid in cash and RMB5 million will be paid in shares of the Company's common stock.
In 2020, the vast majority of adults in America will be overweight or obese and more than half will suffer from diabetes or pre-diabetic conditions, according to projections presented by Northwestern Medicine researchers at the American Heart Association (AHA) Scientific Sessions Wednesday, Nov. 16, in Orlando.
Diabetic kidney disease is one of the most severe complications of type 1 diabetes, and diabetes is the most important cause of end-stage renal disease (ESRD; severely impaired kidney function, requiring dialysis) in industrialized countries, according to background information in the article. Data on patients' risk of developing ESRD are sparse.
NeuroTherapeutics Pharma, Inc. (NTP), a biopharmaceutical company focused on developing novel therapies for central nervous system (CNS) disorders, announced today that it closed a $43 million Series B financing. New investors include Fidelity Biosciences, MPM Capital and SR One, who co-led the transaction, and Pfizer, Inc. Existing investors Novo Ventures and Thomas McNerney & Partners also participated in the round.
› Verified 7 days ago
Mr. Daniel Bernard Enimpah, LPN Licensed Practical Nurse Medicare: Not Enrolled in Medicare Practice Location: 3030 Chestnut St, Lebanon, PA 17042 Phone: 717-769-5841 Fax: 717-273-8244 | |
Mrs. Jennice Olan, LPN Licensed Practical Nurse Medicare: Not Enrolled in Medicare Practice Location: 15 N 10th St, Lebanon, PA 17046 Phone: 717-272-0852 | |
Elizabeth Ann Willey, Licensed Practical Nurse Medicare: Not Enrolled in Medicare Practice Location: 3030 Chestnut St, Lebanon, PA 17042 Phone: 717-306-9181 | |
Martha Marie Earhart, Licensed Practical Nurse Medicare: Not Enrolled in Medicare Practice Location: 3030 Chestnut St, Lebanon, PA 17042 Phone: 717-273-8000 Fax: 717-273-8244 | |
Barbara Reeves, Licensed Practical Nurse Medicare: Not Enrolled in Medicare Practice Location: 821 Chestnut St, Lebanon, PA 17042 Phone: 717-293-5104 | |
Rachel Thompson, Licensed Practical Nurse Medicare: Not Enrolled in Medicare Practice Location: 1555 Lafayette St, Lebanon, PA 17042 Phone: 610-834-1122 | |
Kyra Roof, LPN Licensed Practical Nurse Medicare: Not Enrolled in Medicare Practice Location: 15 S 9th St, Lebanon, PA 17042 Phone: 717-273-5992 Fax: 717-273-5995 |